3Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Torontoarea. JAMA, 2003,289: 1-9.
4Donnelly CA, Ghani AC, Leung GM, et al. Epidemiologieal determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet, 2003 ,361 : 1761-1766.
5Lapinsky SE, Hawryluck L. ICU management of severe acute respiratory syndrome. Intensive Care Med, 2003,29 : 870-875.
6Seto WH, Tsang D, Yung R, et al. Effectiveness of precautions against droplets and contact in prevention of osocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003, 361: 1519-1520.
7Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with Severe Acute Respiratory Syndrome. N Engl J Med, 2003,348:1967-1976.
8Cho KO, Hoet AE, Loerch SC, et al. Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle. Am J Vet Res ,2001, 62: 1436-1441.
9Peiris JSM, Chu CM, Cheng VCC, et al. Prospective study of the clinical progression and viral load of SARS associated coronavirus pneumonia in a community outbreak. Lancet ,2003, 361:1767-1772.
10Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet ,2003 ,361 : 1701-1703.
